Kybella
Does stubborn fat under your chin keep you from looking your best? Submental fullness, or more commonly known as a double chin, can hamper your self esteem and distract from your natural beauty. Dr. Day and her team are proud to offer Kybella, a new FDA approved injectable treatment that significantly improves chin contouring without the invasiveness or downtime of surgery.
Kybella works simply by destroying fat cells. The injection consists of a synthetic formulation of deoxycholic acid, a substance found naturally in the body that breaks down and absorbs dietary fat. Once these fat cells are destroyed, they can no longer store or accumulate fat. You will have a permanently more contoured and defined jawline.
If you are recommended Kybella by Dr. Day and her team, you can expect to be with us in the office for approximately one hour. Topical numbing will be used prior to the treatment to ensure you are as comfortable as possible. After the injections, you may bruise and swell. However, most of these bruises are easily covered with makeup and last only a few days. Though the fat dissolves within 10-15 minutes, you may experience significant swelling that can mask the initial effects. The swelling should subside in 1-2 weeks and you should see your final results within 4-6 weeks.
Estrogen Study
This study is being done to see whether applying a cream with estradiol (a form of estrogen) to the face can improve overall skin quality and help reduce fine lines and wrinkles in peri- and post-menopausal women, and how this relates to epigenetic changes in the skin. A part of the study will also include applying an extra rapamycin analog cream to the face, which is also believed to improve overall skin quality and help reduce fine lines and wrinkles.
WHY THIS MATTERS
Skin aging in peri- and post-menopausal women is deeply tied to hormonal shifts. This study explores whether topical estradiol can turn back the clock – cellularly.
Eligibility
You MAY qualify if you can answer YES to all:
I am a healthy female (peri or menopausal) between the ages of 40 and 65.
I have not had any cosmetic facial treatments in the last 1-3 months.
I have not had any GLP-1 treatments in the last 6 months.
Study Design and Duration
The study includes daily evening application of study cream for 12 weeks, followed by 4 weeks with no test product use. In total, the study will last 16 weeks or approximately 4 months.
Topical Scalp Serum Containing RLX‑201 in Subjects With Mild‑to‑Moderate Hair Thinning
Purpose of the Study
The purpose of this study is to evaluate the safety, tolerability, and effectiveness of a scalp serum containing RLX‑201 when applied once daily for 20 weeks in men and women with mild‑to‑moderate hair thinning. The study will assess changes in hair density, hair thickness, and overall scalp health using clinical evaluations, imaging tools, and participant self‑assessments.
Eligibility
You MAY qualify if you can answer YES to all:
I am a healthy male or female between the ages of 30 and 60.
Self‑perceived mild‑to‑moderate hair thinning.
I have NOT used minoxidil, light therapy, or other hair growth treatments within 3 months.
I have NOT used medications affecting hair growth (e.g., finasteride, spironolactone, cyproterone acetate, 5‑alpha‑reductase inhibitors) or a GLP-1 within 6 months.
Study Design and Duration
This is a single‑center clinical study lasting approximately 20 weeks. If you agree to participate, you will be asked to attend study visits at the following time points: Baseline, and Weeks 2, 4, 8, 12, 16, and 20.